CORONAVIRUS AND ITS MAIN PROTEASE: AN INSIGHT FOR DRUGS DESIGN BY MOLECULAR DOCKING
Keyword(s):
Many virus need their sulphydryl groups to be reduced in order to be allowed to enter cells. SARS-CoV-2, which belongs to Coronaviridae family and is responsible for coronavirus disease 2019 or COVID-19, has cysteine-rich proteins in its capsid as the main CoV protease (MPRO), which must be intact and active maintaining the viral activity. Considering that MPRO is an important molecular target for development of antiviral drugs, this work motivation was the structural study of the possible ways of interaction between drugs and viral cysteines by molecular docking technique for design of new potential inhibitors of MPRO and its virulence.
Keyword(s):
Keyword(s):
2020 ◽
pp. 174-178
2021 ◽
Vol 10
(1)
◽
pp. 18
Keyword(s):
2021 ◽
pp. 100-104
2020 ◽
Keyword(s):
2021 ◽
2020 ◽
Keyword(s):
2020 ◽
Vol 754
◽
pp. 137751
◽
Keyword(s):